Cargando…

Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence

PURPOSE: To inform intervention development, we measured the modifiable determinants of endocrine therapy (ET) non-adherence in women with breast cancer, using the Theoretical Domains Framework (TDF) and examined inter-relationships between these determinants and non-adherence using the Perceptions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cahir, Caitriona, Bennett, Kathleen, Dombrowski, Stephan U., Kelly, Catherine M., Wells, Mary, Watson, Eila, Sharp, Linda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985562/ https://www.ncbi.nlm.nih.gov/pubmed/36869943 http://dx.doi.org/10.1007/s00520-023-07658-x

Ejemplares similares

Urban–Rural Variations in Quality-of-Life in Breast Cancer Survivors Prescribed Endocrine Therapy
por: Cahir, Caitriona, et al.
Publicado: (2017)

Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life
por: Stewart, Sarah-Jane F., et al.
Publicado: (2023)

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence
por: Brett, Jo, et al.
Publicado: (2018)

The psychosocial determinants of quality of life in breast cancer survivors: a scoping review
por: Culbertson, Michael G., et al.
Publicado: (2020)

Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer
por: Brett, Jo, et al.
Publicado: (2018)

Mapping the use of Group-Based Trajectory Modelling in medication adherence research: A scoping review protocol
por: Walsh, Caroline A., et al.
Publicado: (2020)

Costs associated with adverse drug reactions in an older population admitted to hospital: a prospective cohort study
por: Bennett, Kathleen, et al.
Publicado: (2023)

Breast cancer care amidst a pandemic: a scoping review to understand the impact of coronavirus disease 2019 on health services and health outcomes
por: Myers, Charlotte, et al.
Publicado: (2023)

Pharmacoepidemiology resources in Ireland—an introduction to pharmacy claims data
por: Sinnott, Sarah-Jo, et al.
Publicado: (2017)

Prescriber variation in potentially inappropriate prescribing in older populations in Ireland
por: Cahir, Caitriona, et al.
Publicado: (2014)

Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models
por: Moriarty, Frank, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on women living with and beyond breast cancer: a qualitative study of women’s experiences and how they varied by social determinants of health
por: Myers, Charlotte, et al.
Publicado: (2023)

Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review
por: Toivonen, Kirsti I., et al.
Publicado: (2020)

Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
por: Rosso, Roberta, et al.
Publicado: (2023)

Impact of drug burden index on adverse health outcomes in Irish community-dwelling older people: a cohort study
por: Byrne, Catherine J., et al.
Publicado: (2019)

Interventional Tools to Improve Prescription and Adherence to Medical Plans
por: Costa, Elísio, et al.
Publicado: (2015)

A nested case–control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I–III breast cancer
por: Barron, T I, et al.
Publicado: (2013)

Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
por: Cahir, Caitriona, et al.
Publicado: (2012)

Agreement between self-reported morbidity and pharmacy claims data for prescribed medications in an older community based population
por: Mannion, Clionadh, et al.
Publicado: (2020)

Prevalence of Drug–Drug Interactions in Older Community-Dwelling Individuals: A Systematic Review and Meta-analysis
por: Hughes, John E., et al.
Publicado: (2023)

Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people
por: Moriarty, Frank, et al.
Publicado: (2015)

Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
por: Lee, Joo Yun, et al.
Publicado: (2018)

A Survey of Potentially Modifiable Patient-Level Factors Associated with Self-Report and Objectively Measured Adherence to Adjuvant Endocrine Therapies After Breast Cancer
por: Toivonen, Kirsti I, et al.
Publicado: (2021)

Oncologists’ perspectives on adherence/non-adherence to adjuvant endocrine therapy and management strategies in women with breast cancer
por: Eraso, Yolanda
Publicado: (2019)

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
por: Makubate, B, et al.
Publicado: (2013)

Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy
por: Tan, Eng Hooi, et al.
Publicado: (2021)

Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer
por: Lambert, Leah K., et al.
Publicado: (2021)

Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study
por: Hughes, John E., et al.
Publicado: (2021)

Potentially inappropriate prescribing and its association with health outcomes in middle-aged people: a prospective cohort study in Ireland
por: Moriarty, Frank, et al.
Publicado: (2017)

Anticholinergic and sedative drug burden in community-dwelling older people: a national database study
por: Byrne, Catherine J, et al.
Publicado: (2018)

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
por: Wulaningsih, W., et al.
Publicado: (2018)

Adverse Drug reactions in an Ageing PopulaTion (ADAPT) study protocol: a cross-sectional and prospective cohort study of hospital admissions related to adverse drug reactions in older patients
por: Cahir, Caitriona, et al.
Publicado: (2017)

Does patient health literacy impact adherence to adjuvant endocrine therapy in breast cancer patients?
por: Keim-Malpass, Jessica, et al.
Publicado: (2018)

Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore
por: Ali, Eskinder Eshetu, et al.
Publicado: (2017)

Psychometric properties of the Beliefs about Medicine Questionnaire–adjuvant endocrine therapy (BMQ-AET) for women taking AETs following early-stage breast cancer
por: Brett, Jo, et al.
Publicado: (2017)

‘Everyone should know what they’re on’: a qualitative study of attitudes towards and use of patient held lists of medicines among patients, carers and healthcare professionals in primary and secondary care settings in Ireland
por: O'Donovan, Bernadine, et al.
Publicado: (2022)

Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
por: Villarreal-Garza, Cynthia, et al.
Publicado: (2021)

Improving Adherence to Adjuvant Endocrine Therapy in Sub-Saharan Africa: Challenges and Innovative Nurse-Driven Solutions
por: Fadelu, Temidayo A, et al.
Publicado: (2022)

Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients
por: Cahir, Caitriona, et al.
Publicado: (2023)

‘It’s a can of worms’: understanding primary care practitioners’ behaviours in relation to HPV using the theoretical domains framework
por: McSherry, Lisa A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l9p95itfqim09hcar6tcal3isl